Claims
- 1. A method for culturing human embryonic stem cells comprising culturing the stem cells in a nutrient medium in which the stem cells will remain undifferentiated and in an atmosphere having no more than about 5% oxygen.
- 2. The method of claim 1 wherein the medium further comprises an antioxidant in the nutrient medium.
- 3. An improvement in methods for cloning cultures of human embryonic stem cells, the improvement comprising culturing the human embryonic stem cells prior to cloning in a nutrient medium and in an atmosphere having no more than about 5% oxygen.
- 4. The improvement of claim 3 further comprising adding an antioxidant to the nutrient medium in which the stem cells are cultured.
- 5. A method for culturing human embryonic stem cells comprising culturing the stem cells in a nutrient medium in which the stem cells can remain undifferentiated and in an atmosphere having no more than about 5% oxygen.
- 6. An improvement in a medium for the cultivation of human embryonic stem cells, the improvement comprising that the medium is adjusted to have an osmolarity in excess of 330 mOsMol.
- 7. The improvement as claimed in claim 6 wherein the osmolarity of the medium is about 350 mOsMol.
- 8. A stem cell culture comprising
a culture plate; a nutrient medium in the culture plate; growing human embryonic stem cells in the medium; and the medium having an osmolarity in excess of 330 mOsMol.
- 9. A stem cell culture as claimed in claim 8 wherein the osmolarity is about 350 mOsMol.
- 10. A method for culturing human embryonic stem cells comprising culturing the stem cells in a nutrient medium in which the stem cells will remain undifferentiated, the medium having an osmolarity in excess of 330 mOsMol.
- 11. A method as claimed in claim 10 wherein the medium has an osmolarity of about 350 mOsMol.
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority from U.S. provisional patent application Ser. No. 60/458,815 filed Mar. 28, 2003.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
[0002] This invention was made with United States government support awarded by the following agencies: NIH RR17721. The United States has certain rights in this invention.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60458815 |
Mar 2003 |
US |